In an article from Forbes.com, reporters check into recent news that Novartis has begun to make freely accessible the data from some genetic research it's completed. The article quotes Novartis research chief Mark Fishman as saying, ""It will take the entire world to interpret these data. ... We figure we will benefit more by having a lot of companies look at these data than by holding it secret." Does this mean pharma's going open source? We can always hope.
FAA Says: No Pigs Flying Yet
Feb 14, 2007
What's Popular?